Your Feed

Filter by
See content from
Back to the latest
Avatar
Lareeree
Multiple Myeloma Discussion • September 1, 2023
Preparing for CAR-T Post-SCT: Any Tips?
AI-generated title
Hello Community, I am just about to begin the lympho-depleting chemo for Car T. I am diagnosed with MM since 2019 and just recently had an in-patient stem cell transplant as a bridge to my Car T, as my disease was so aggressive and relapsing constantly. I am 36 days post SCT and a little weary of going back into the hospital, but excited about finally getting Car T therapy and hoping to put these aggressive relapses behind me. Any advice for how I might fair well with this process? Thanks Brave Ones!
Avatar
Qunbin
Multiple Myeloma Discussion • August 31, 2023
Join a Webinar on Advanced AL Treatments
AI-generated title
Greetings! Please join us for a live Webinar event. Beyond Standard of Care Treatment for Light Chain (AL) Amyloidosis: The Promise of Tomorrow Presented by Heather Landau, MD Tuesday, September 26, 2023 3:00 PM ET Register here: https://www.pathlms.com/amyloidosis/webinars/36919 Heather Landau, MD, is a hematologist-oncologist and the Director of the Amyloid Program at Memorial Sloan Kettering (MSK) Cancer Center focused on increasing access to novel, effective therapies in AL amyloidosis and has investigated drugs at all stages of development. She has conducted multiple investigator-initiated clinical trials exploring novel agents and approaches, including consolidation and maintenance strategies in high-risk patients. She led the development of MSK’s Outpatient Transplant Service and is studying innovative ways to optimize high-dose therapy and transplant care. Pharmacokinetically dosed conditioning has the potential to truly personalize high-dose therapy and Dr. Landau has shown that delivering transplant care at home is safe and improves the quality of life and satisfaction of patients and caregivers.